Novavax's COVID-19 vaccine approved for Canadians 18 and over February 17, 2022 Novavax's COVID-19 vaccine has been approved for use in Canadian adults, some 18 months after the federal government had announced a deal to produce the doses in Montreal. Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.